Respiratory syncytial virus (RSV) infections lead to hundreds of infant hospitalizations each year in Denmark, particularly among those under three months old.
To prevent disease and hospitalizations among infants, the government has launched a new RSV seasonal vaccination programme for pregnant women; they will be offered the vaccine during a pregnancy check-up with their doctor in the 32nd week of pregnancy.
Initially planned for May 2026, the programme was launched earlier, with pregnant women offered the vaccine starting in autumn 2025 to provide earlier protection during the peak RSV season. The government proposes to allocate DKK 35.9 million (€4.8 million) in 2026 and DKK 40.2 million (€5.4 million) in 2027 to introduce the new vaccination programme.